The ARF tumor suppressor can promote the progression of some tumors

Cancer Research

Volumn 68, Issue 23, 2008, Pages 9608-9613

  Humbey, Olivier ^a   Pimkina, Julia ^a   Zilfou, Jack T ^b   Jarnik, Michal ^a   Dominguez Brauer, Carmen ^c   Burgess, Darren J ^d   Eischen, Christine M ^e   Murphy, Maureen E ^a  

^a FOX CHASE CANCER CENTER   (United States)

^b Zilfou Therapeutics Inc   (United States)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^d Howard Hughes Medical Institute Cold Spring Harbor Laboratory Cold Spring Harbor   (United States)

^e VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARF PROTEIN; MUTANT PROTEIN; MYC PROTEIN; PROTEIN P53; RAS PROTEIN; TUMOR SUPPRESSOR PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARF GENE; ARTICLE; AUTOPHAGY; CELL VIABILITY; CONTROLLED STUDY; EMBRYO; GENE MUTATION; GENE SILENCING; LYMPHOMA; MOUSE; NONHUMAN; NUTRIENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TUMOR GROWTH; TUMOR SUPPRESSOR GENE; UPREGULATION;

ANIMALS; AUTOPHAGY; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DISEASE PROGRESSION; FIBROBLASTS; GENE SILENCING; GENES, TUMOR SUPPRESSOR; HUMANS; LYMPHOMA, B-CELL; MICE; MICE, KNOCKOUT; MICE, SCID; RNA, MESSENGER; TUMOR SUPPRESSOR PROTEIN P53; UP-REGULATION;

EID: 57149103500     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-08-2263     Document Type: Article

References (20)

1. Sherr CJ, Bertwistle D, Den Besten W, et al. p53-dependent and -independent functions of the Arf tumor suppressor. Cold Spring Harb Symp Quant Biol 2005;70:129-37.
2. Basso K, Margolin AA, Stolovitzky G, Klein U, Dalla-Favera R, Califano A. Reverse engineering of regulatory networks in human B cells. Nat Genet 2005;37:382-90.
3. Eischen CM, Weber JD, Roussel MF, Sherr CJ, Cleveland JL. Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis. Genes Dev 1999;13:2658-69.
4. Kamijo T, Weber JD, Zambetti G, Zindy F, Roussel MF, Sherr CJ. Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2. Proc Natl Acad Sci U S A 1998;95:8292-7.
5. Reef S, Zalckvar E, Shifman O, et al. A short mitochondrial form of p19ARF induces autophagy and caspase-independent cell death. Mol Cell 2006;22:463-75.
6. Ueda Y, Koya T, Yoneda-Kato N, Kato JY. Small mitochondrial ARF (smARF) is located in both the nucleus and cytoplasm, induces cell death, and activates p53 in mouse fibroblasts. FEBS Lett 2008;582:1459-64.
7. Abida WM, Gu W. p53-dependent and independent activation of autophagy by ARF. Cancer Res 2008;68:352-7.
8. Jin S, White E. Role of autophagy in cancer: management of metabolic stress. Autophagy 2007;3:28-31.
9. Weber JD, Jeffers JR, Rehg JE, et al. p53-independent functions of the p19(ARF) tumor suppressor. Genes Dev 2000;14:2358-65.
10. Hemann MT, Fridman JS, Zilfou JT, et al. An epiallelic series of p53 hypomorphs created by stable RNAi produces distinct tumor phenotypes in vivo. Nat Genet 2003;33:396-400.
11. Paddison PJ, Cleary M, Silva JM, et al. Cloning of short hairpin RNAs for gene knockdown in mammalian cells. Nat Methods 2004;1:163-7.
12. Dickins RA, Hemann MT, Zilfou JT, et al. Probing tumor phenotypes using stable and regulated synthetic microRNA precursors. Nat Genet 2005;37:1289-95.
13. Pietsch EC, Leu JI, Frank A, Dumont P, George DL, Murphy ME. The tetramerization domain of p53 is required for efficient BAK oligomerization. Cancer Biol Ther 2007;6:1576-83.
14. Tokuyasu KT. Immunochemistry on ultrathin frozen sections. Histochem J 1980;12:381-403.
15. Pattingre S, Petiot A, Codogno P. Analyses of G-α-interacting protein and activator of G-protein-signaling-3 functions in macroautophagy. Methods Enzymol 2004;390:17-31.
16. Robertson KD, Jones PA. The human ARF cell cycle regulatory gene promoter is a CpG island which can be silenced by DNA methylation and down-regulated by wild-type p53. Mol Cell Biol 1998;18:6457-73.
17. Inoue R, Asker C, Klangby U, Pisa P, Wiman KG. Induction of the human ARF protein by serum starvation. Anticancer Res 1999;19:2939-43.
18. Amaravadi RK, Yu D, Lum JJ, et al. Autophagy inhibition enhances therapy-induced apoptosis in a Myc-induced model of lymphoma. J Clin Invest 2007;117:326-36.
19. Carew JS, Nawrocki ST, Kahue CN, et al. Targeting autophagy augments the anticancer activity of the histone deacetylase inhibitor SAHA to overcome Bcr-Abl-mediated drug resistance. Blood 2007;110:313-22.
20. Furuta S, Hidaka E, Ogata A, Yokota S, Kamata T. Ras is involved in the negative control of autophagy through the class I PI3-kinase. Oncogene 2004;23:3898-904.